scPharmaceuticals Inc. Announces Positive ResultsSCPH: scPharmaceuticals, Inc. 2022-07-12 08:00:00 scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure Longby MarketMoversReport0
NDA filling expected mid 2020Consensus Price Target: $9.00 Simple risk / reward trade here Longby UnknownUnicorn20343813
